PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F13JM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $622,056
Award facts
- Contract value 100% obligated
- $622,055.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $622,055.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, carries no set-aside designation and represents a competitively awarded contract. The vendor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp maintains a substantial portfolio of federal pharmaceutical and medical supply contracts, supplying a broad range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record of competitively awarded contracts demonstrates its capability to meet federal procurement requirements. The parent organization, Cencora, Inc., also holds a separate significant IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, further solidifying the company's role as a critical vendor in the federal medical procurement landscape.
Quick answers
Who was awarded contract SPE2D826F13JM?
SPE2D826F13JM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F13JM worth?
The government has obligated $622,056 on SPE2D826F13JM.
Is contract SPE2D826F13JM an order under another contract?
Yes. SPE2D826F13JM is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F13JM competed?
The extent of competition for SPE2D826F13JM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award